Close

Benchmark Upgrades Ceradyne (CRDN) to Buy; Expect Upcoming Body Armor Awards to Support Strong FY10-11

September 1, 2010 8:34 AM EDT Send to a Friend
Benchmark upgrades Ceradyne (Nasdaq: CRDN) from Hold to Buy. PT $26.

Benchmark analyst says, "Our upgrade is based on improving ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login